# Community Healthcare Trust Inc: overview

CHCT · NYSE · CIK 1631569 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chct.md) · [Financials](/companies/chct/financials.md) · [Filings](/companies/chct/filings.md) · [Insiders](/companies/chct/insiders.md)

Latest reported revenue: [$31.2m](/filings/0001631569-26-000038.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:Revenues, accession 0001631569-26-000038).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.6](/filings/0001631569-25-000091.md) | [29.3 d](/filings/0001631569-26-000012.md) | [30.1](/filings/0001631569-26-000026.md) | [29.1](/filings/0001631569-26-000038.md) | [31.1](/filings/0001631569-25-000091.md) | [30.9 d](/filings/0001631569-26-000012.md) | [31.5](/filings/0001631569-26-000026.md) | [31.2](/filings/0001631569-26-000038.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [5.9%](/filings/0001631569-25-000091.md) | [6.3% d](/filings/0001631569-26-000012.md) | [5.3%](/filings/0001631569-26-000026.md) | [(43.2%)](/filings/0001631569-26-000038.md) | [5.3%](/filings/0001631569-25-000091.md) | [46.6% d](/filings/0001631569-26-000012.md) | [8.1%](/filings/0001631569-26-000026.md) | [7.6%](/filings/0001631569-26-000038.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001631569-25-000091.md) | not reported | [0.03](/filings/0001631569-26-000026.md) | [(0.50)](/filings/0001631569-26-000038.md) | [0.03](/filings/0001631569-25-000091.md) | not reported | [0.07](/filings/0001631569-26-000026.md) | [0.06](/filings/0001631569-26-000038.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [90.6](/filings/0001631569-24-000024.md) | [97.7](/filings/0001631569-25-000015.md) | [113](/filings/0001631569-26-000012.md) | [116](/filings/0001631569-26-000012.md) | [121](/filings/0001631569-26-000012.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [24.8%](/filings/0001631569-24-000024.md) | [22.5%](/filings/0001631569-25-000015.md) | [6.8%](/filings/0001631569-26-000012.md) | [(2.7%)](/filings/0001631569-26-000012.md) | [4.2%](/filings/0001631569-26-000012.md) |
| Diluted EPS | $ per share | [0.87](/filings/0001631569-24-000024.md) | [0.81](/filings/0001631569-25-000015.md) | [0.20](/filings/0001631569-26-000012.md) | [(0.23)](/filings/0001631569-26-000012.md) | [0.08](/filings/0001631569-26-000012.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/chct/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $48.2m | 2,637,919 |  | Reduced −49,279 |
| [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $37.6m | 2,057,305 |  | Added +71,962 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $26.7m | 1,458,228 |  | Reduced −15,576 |
| [SYSTEMATIC FINANCIAL MANAGEMENT LP](/funds/1085936.md) | 2026-06-30 | $21.6m | 1,183,409 |  | Added +58,523 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $21.6m | 1,181,281 |  | Added +22,918 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $17.9m | 979,051 |  | Added +145,310 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $17.2m | 943,390 |  | Added +62,201 |
| [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $15.9m | 872,381 |  | Reduced −39,614 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $15.1m | 827,440 |  | Added +51,475 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $14.9m | 813,920 |  | Added +60,884 |

## Recent filings

[All 603 filings](/companies/chct/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-04 | 16:19 ET | [8-K](/filings/0001631569-26-000039.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001631569-26-000039 |
| 2026-08-04 | 16:17 ET | [10-Q](/filings/0001631569-26-000038.md) | Quarterly report, period 2026-06-30 | 0001631569-26-000038 |
| 2026-05-07 | 16:19 ET | [8-K](/filings/0001631569-26-000031.md) | 5.07 Shareholder vote results | 0001631569-26-000031 |
| 2026-05-05 | 16:17 ET | [10-Q](/filings/0001631569-26-000026.md) | Quarterly report, period 2026-03-31 | 0001631569-26-000026 |
| 2026-05-05 | 16:17 ET | [8-K](/filings/0001631569-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001631569-26-000027 |
| 2026-03-12 | 16:15 ET | [DEF 14A](/filings/0001631569-26-000021.md) | Proxy statement, period 2026-05-07 | 0001631569-26-000021 |
| 2026-02-17 | 16:32 ET | [8-K](/filings/0001631569-26-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001631569-26-000013 |
| 2026-02-17 | 16:17 ET | [10-K](/filings/0001631569-26-000012.md) | Annual report, period 2025-12-31 | 0001631569-26-000012 |
| 2026-01-09 | 16:15 ET | [8-K](/filings/0001104659-26-002475.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-002475 |
| 2025-10-29 | 06:15 ET | [8-K/A](/filings/0001104659-25-103394.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-103394 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001631569-26-000012.md), filed Feb 17, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/59edc705-ed11-44f3-9750-6c1c2c2a2c1b)

## About the filer

- CIK: 1631569
- Tickers: CHCT
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.